• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多个桩蛋白结合位点调节黏着斑激酶功能。

Multiple paxillin binding sites regulate FAK function.

作者信息

Scheswohl Danielle M, Harrell Jessica R, Rajfur Zenon, Gao Guanghua, Campbell Sharon L, Schaller Michael D

机构信息

Department of Cell and Developmental Biology, University of North Carolina, Chapel Hill, North Carolina 27599, USA.

出版信息

J Mol Signal. 2008 Jan 2;3:1. doi: 10.1186/1750-2187-3-1.

DOI:10.1186/1750-2187-3-1
PMID:18171471
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2246129/
Abstract

BACKGROUND

FAK localization to focal adhesions is essential for its activation and function. Localization of FAK is mediated through the C-terminal focal adhesion targeting (FAT) domain. Recent structural analyses have revealed two paxillin-binding sites in the FAT domain of FAK. To define the role of paxillin binding to each site on FAK, point mutations have been engineered to specifically disrupt paxillin binding to each docking site on the FAT domain of FAK individually or in combination.

RESULTS

These mutants have been characterized and reveal an important role for paxillin binding in FAK subcellular localization and signaling. One paxillin-binding site (comprised of alpha-helices 1 and 4 of the FAT domain) plays a more prominent role in localization than the other. Mutation of either paxillin-binding site has similar effects on FAK activation and downstream signaling. However, the sites aren't strictly redundant as each mutant exhibits phosphorylation/signaling defects distinct from wild type FAK and a mutant completely defective for paxillin binding.

CONCLUSION

The studies demonstrate that the two paxillin-binding sites of FAK are not redundant and that both sites are required for FAK function.

摘要

背景

粘着斑激酶(FAK)定位于粘着斑对于其激活和功能至关重要。FAK的定位是通过C端粘着斑靶向(FAT)结构域介导的。最近的结构分析揭示了FAK的FAT结构域中有两个桩蛋白结合位点。为了确定桩蛋白与FAK上每个位点结合的作用,已设计出点突变,以特异性破坏桩蛋白分别或联合与FAK的FAT结构域上每个对接位点的结合。

结果

这些突变体已得到表征,并揭示了桩蛋白结合在FAK亚细胞定位和信号传导中的重要作用。一个桩蛋白结合位点(由FAT结构域的α螺旋1和4组成)在定位中比另一个发挥更突出的作用。任一桩蛋白结合位点的突变对FAK激活和下游信号传导具有相似的影响。然而,这些位点并非完全冗余,因为每个突变体都表现出与野生型FAK不同的磷酸化/信号缺陷,以及一个对桩蛋白结合完全有缺陷的突变体。

结论

研究表明,FAK的两个桩蛋白结合位点并非冗余,且两个位点对于FAK功能都是必需的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3092/2246129/e4381b0d251c/1750-2187-3-1-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3092/2246129/81ae8df8d2f2/1750-2187-3-1-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3092/2246129/3a235788b5da/1750-2187-3-1-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3092/2246129/b308b0c7858e/1750-2187-3-1-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3092/2246129/610996ea5c86/1750-2187-3-1-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3092/2246129/e4381b0d251c/1750-2187-3-1-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3092/2246129/81ae8df8d2f2/1750-2187-3-1-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3092/2246129/3a235788b5da/1750-2187-3-1-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3092/2246129/b308b0c7858e/1750-2187-3-1-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3092/2246129/610996ea5c86/1750-2187-3-1-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3092/2246129/e4381b0d251c/1750-2187-3-1-5.jpg

相似文献

1
Multiple paxillin binding sites regulate FAK function.多个桩蛋白结合位点调节黏着斑激酶功能。
J Mol Signal. 2008 Jan 2;3:1. doi: 10.1186/1750-2187-3-1.
2
Identification of LIM3 as the principal determinant of paxillin focal adhesion localization and characterization of a novel motif on paxillin directing vinculin and focal adhesion kinase binding.确定LIM3是桩蛋白粘着斑定位的主要决定因素,并对桩蛋白上指导纽蛋白和粘着斑激酶结合的新基序进行表征。
J Cell Biol. 1996 Nov;135(4):1109-23. doi: 10.1083/jcb.135.4.1109.
3
Paxillin binding is not the sole determinant of focal adhesion localization or dominant-negative activity of focal adhesion kinase/focal adhesion kinase-related nonkinase.桩蛋白结合并非粘着斑定位或粘着斑激酶/粘着斑激酶相关非激酶的显性负性活性的唯一决定因素。
Mol Biol Cell. 2000 Sep;11(9):3247-63. doi: 10.1091/mbc.11.9.3247.
4
Complex formation with focal adhesion kinase: A mechanism to regulate activity and subcellular localization of Src kinases.与粘着斑激酶形成复合物:一种调节Src激酶活性和亚细胞定位的机制。
Mol Biol Cell. 1999 Oct;10(10):3489-505. doi: 10.1091/mbc.10.10.3489.
5
NMR solution structure of the focal adhesion targeting domain of focal adhesion kinase in complex with a paxillin LD peptide: evidence for a two-site binding model.粘着斑激酶粘着斑靶向结构域与桩蛋白LD肽复合物的核磁共振溶液结构:双位点结合模型的证据
J Biol Chem. 2004 Feb 27;279(9):8441-51. doi: 10.1074/jbc.M309808200. Epub 2003 Dec 7.
6
The role of focal adhesion kinase binding in the regulation of tyrosine phosphorylation of paxillin.粘着斑激酶结合在桩蛋白酪氨酸磷酸化调节中的作用
J Biol Chem. 1999 Dec 17;274(51):36684-92. doi: 10.1074/jbc.274.51.36684.
7
Focal adhesion targeting: the critical determinant of FAK regulation and substrate phosphorylation.粘着斑靶向:粘着斑激酶调节和底物磷酸化的关键决定因素。
Mol Biol Cell. 1999 Aug;10(8):2507-18. doi: 10.1091/mbc.10.8.2507.
8
Src and FAK kinases cooperate to phosphorylate paxillin kinase linker, stimulate its focal adhesion localization, and regulate cell spreading and protrusiveness.Src激酶和黏着斑激酶(FAK)协同作用,使桩蛋白激酶连接区磷酸化,刺激其在黏着斑中的定位,并调节细胞铺展和突出性。
Mol Biol Cell. 2005 Sep;16(9):4316-28. doi: 10.1091/mbc.e05-02-0131. Epub 2005 Jul 6.
9
A non-canonical role for Rgnef in promoting integrin-stimulated focal adhesion kinase activation.Rgnef 在促进整合素刺激的黏着斑激酶激活中的非经典作用。
J Cell Sci. 2013 Nov 1;126(Pt 21):5074-85. doi: 10.1242/jcs.135509. Epub 2013 Sep 4.
10
GIT1 utilizes a focal adhesion targeting-homology domain to bind paxillin.GIT1利用一个粘着斑靶向同源结构域来结合桩蛋白。
Cell Signal. 2007 Aug;19(8):1733-44. doi: 10.1016/j.cellsig.2007.03.010. Epub 2007 Mar 30.

引用本文的文献

1
Conformational dynamics and multimodal interaction of Paxillin with the focal adhesion targeting domain.桩蛋白与粘着斑靶向结构域的构象动力学及多模态相互作用
Sci Adv. 2025 Jun 20;11(25):eadt9936. doi: 10.1126/sciadv.adt9936. Epub 2025 Jun 18.
2
Structure-based discovery of hydrocarbon-stapled paxillin peptides that block FAK scaffolding in cancer.基于结构发现可阻断癌症中粘着斑激酶支架作用的烃链稳定化桩蛋白肽。
Nat Commun. 2025 Feb 28;16(1):2060. doi: 10.1038/s41467-025-57196-9.
3
Conformational dynamics and multi-modal interaction of Paxillin with the Focal Adhesion Targeting Domain.

本文引用的文献

1
The role of focal-adhesion kinase in cancer - a new therapeutic opportunity.粘着斑激酶在癌症中的作用——一种新的治疗机遇。
Nat Rev Cancer. 2005 Jul;5(7):505-15. doi: 10.1038/nrc1647.
2
Requirement for focal adhesion kinase in the early phase of mammary adenocarcinoma lung metastasis formation.乳腺腺癌肺转移形成早期对焦黏着激酶的需求。
Cancer Res. 2005 Jun 1;65(11):4698-706. doi: 10.1158/0008-5472.CAN-04-4126.
3
Microtubule-induced focal adhesion disassembly is mediated by dynamin and focal adhesion kinase.微管诱导的粘着斑解体由发动蛋白和粘着斑激酶介导。
桩蛋白与粘着斑靶向结构域的构象动力学及多模态相互作用
bioRxiv. 2025 Jan 2:2025.01.01.630265. doi: 10.1101/2025.01.01.630265.
4
Evaluation of Paxillin Expression in Epithelial Dysplasia, Oral Squamous Cell Carcinoma, Lichen Planus with and without Dysplasia, and Hyperkeratosis: A Retrospective Cross-Sectional Study.帕西利蛋白在上皮发育异常、口腔鳞状细胞癌、伴或不伴发育异常的扁平苔藓及角化病中的表达评估:一项回顾性横断面研究
Diagnostics (Basel). 2023 Jul 25;13(15):2476. doi: 10.3390/diagnostics13152476.
5
Paxillin regulates Rab5-mediated vesicle motility through modulating microtubule acetylation.桩蛋白通过调节微管乙酰化来调节 Rab5 介导的囊泡运动。
Mol Biol Cell. 2023 Jun 1;34(7):ar65. doi: 10.1091/mbc.E22-10-0455. Epub 2023 Apr 12.
6
Synergistic phase separation of two pathways promotes integrin clustering and nascent adhesion formation.两种途径的协同相分离促进整合素聚集和新生黏附形成。
Elife. 2022 Jan 20;11:e72588. doi: 10.7554/eLife.72588.
7
Paxillin promotes breast tumor collective cell invasion through maintenance of adherens junction integrity.桩蛋白通过维持黏着连接的完整性促进乳腺癌细胞的集体侵袭。
Mol Biol Cell. 2022 Feb 1;33(2):ar14. doi: 10.1091/mbc.E21-09-0432. Epub 2021 Dec 1.
8
Drug Discovery Targeting Focal Adhesion Kinase (FAK) as a Promising Cancer Therapy.靶向黏着斑激酶(FAK)的药物研发:一种有前景的癌症治疗策略。
Molecules. 2021 Jul 13;26(14):4250. doi: 10.3390/molecules26144250.
9
FAK displacement from focal adhesions: a promising strategy to target processes implicated in cancer progression and metastasis.黏着斑激酶(FAK)从黏着斑的位移:一种有前途的靶向策略,针对癌症进展和转移中涉及的过程。
Cell Commun Signal. 2021 Jan 7;19(1):3. doi: 10.1186/s12964-020-00671-1.
10
Development of a Fragment-Based Screening Assay for the Focal Adhesion Targeting Domain Using SPR and NMR.利用 SPR 和 NMR 开发基于片段的粘着斑靶向结构域筛选测定法。
Molecules. 2019 Sep 14;24(18):3352. doi: 10.3390/molecules24183352.
Nat Cell Biol. 2005 Jun;7(6):581-90. doi: 10.1038/ncb1262. Epub 2005 May 15.
4
Structural features of the focal adhesion kinase-paxillin complex give insight into the dynamics of focal adhesion assembly.粘着斑激酶-桩蛋白复合物的结构特征有助于深入了解粘着斑组装的动力学。
Protein Sci. 2005 Mar;14(3):644-52. doi: 10.1110/ps.041107205. Epub 2005 Feb 2.
5
Paxillin: adapting to change.桩蛋白:适应变化。
Physiol Rev. 2004 Oct;84(4):1315-39. doi: 10.1152/physrev.00002.2004.
6
The focal adhesion targeting domain of focal adhesion kinase contains a hinge region that modulates tyrosine 926 phosphorylation.粘着斑激酶的粘着斑靶向结构域包含一个调节酪氨酸926磷酸化的铰链区。
Structure. 2004 May;12(5):881-91. doi: 10.1016/j.str.2004.02.028.
7
NMR solution structure of the focal adhesion targeting domain of focal adhesion kinase in complex with a paxillin LD peptide: evidence for a two-site binding model.粘着斑激酶粘着斑靶向结构域与桩蛋白LD肽复合物的核磁共振溶液结构:双位点结合模型的证据
J Biol Chem. 2004 Feb 27;279(9):8441-51. doi: 10.1074/jbc.M309808200. Epub 2003 Dec 7.
8
FAK regulates biological processes important for the pathogenesis of cancer.粘着斑激酶(FAK)调节对癌症发病机制至关重要的生物学过程。
Cancer Metastasis Rev. 2003 Dec;22(4):359-74. doi: 10.1023/a:1023725029589.
9
Targeting membrane-localized focal adhesion kinase to focal adhesions: roles of tyrosine phosphorylation and SRC family kinases.将膜定位的粘着斑激酶靶向粘着斑:酪氨酸磷酸化和Src家族激酶的作用。
J Biol Chem. 2003 Aug 1;278(31):29115-20. doi: 10.1074/jbc.M212396200. Epub 2003 May 16.
10
Heregulin and HER2 signaling selectively activates c-Src phosphorylation at tyrosine 215.Heregulin与HER2信号传导选择性激活酪氨酸215位点的c-Src磷酸化。
FEBS Lett. 2003 May 22;543(1-3):76-80. doi: 10.1016/s0014-5793(03)00404-6.